| Financial Year |
March 31 2023 |
| Monetary Funds |
3,065,611,611.98 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,304,888,424.34 |
| Accounts Receivable |
638,092,722.53 |
| Advances to Suppliers |
66,661,325.70 |
| Other Receivables |
36,666,528.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
123,763,905.38 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
96,772.50 |
| Other Current Assets |
59,016,551.04 |
| Total Current Assets |
5,294,797,842.37 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
12,623,548.96 |
| Long-term Equity Investment |
514,055,744.26 |
| Investment Properties |
-- |
| Fixed Assetes |
6,307,704,656.52 |
| Under-construction Projects |
41,732,833.06 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,251,185,860.23 |
| R&D expenses |
-- |
| Goodwill |
2,318,751.09 |
| Long-Term Deferred and Prepaid Expenses |
65,722,171.66 |
| Deferred Income Tax Assets |
189,125,560.76 |
| Other Non-Current Assets |
38,062,500.00 |
| Sub-Total of Non-Current Assets |
9,553,422,205.73 |
| Total Assets |
14,848,220,048.10 |
| Short-Term Loans |
4,223,855,514.23 |
| Trading Financial liabilities |
-- |
| Notes Payable |
952,814,462.36 |
| Accounts Payable |
1,589,715,826.45 |
| Accounts Received In Advance |
1,356,315.00 |
| Employee Compensation Payable |
311,581,080.04 |
| Taxes Payable |
240,362,478.02 |
| Interest Payable |
-- |
| Dividend Payable |
32,195.20 |
| Other payables |
243,305,025.67 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
441,004,138.50 |
| Other Current Liabilities |
10,241,535.94 |
| Sub-Total of Current Liabilities |
8,133,486,058.93 |
| Long-term Loans |
80,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
145,346,548.96 |
| Special Payable |
-- |
| Estimatied Liabilities |
467,841,841.55 |
| Deferred Income Tax Liabilities |
160,122,485.32 |
| Other Non-Current Liabilities |
37,015,792.29 |
| Sub-Total of Non-Current Liabilities |
1,036,993,723.62 |
| Total Liabilities |
9,170,479,782.55 |
| Paid-In Capital(Or Share Stock) |
1,322,017,394.00 |
| Capital Surplus |
3,420,541,409.34 |
| Surplus Reserve |
153,401,674.18 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
545,203,707.56 |
| Minority Stockholder's Interest |
-1,665,117.96 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,679,405,383.51 |
| Owner's Equity（Stockholder's Equity） |
5,677,740,265.55 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,848,220,048.10 |
